Published: 26 July 2019

Publications

Information released under the OIA on sodium valproate (Epilim)

Medsafe is publishing documents released under the OIA requesting information on sodium valproate (Epilim).

1. OIA letter regarding sodium valproate (Epilim) (PDF 5,045 KB, 8 pages)
2. DAAC minutes (PDF 36,454 KB, 81 pages)
3. Medsafe mailouts (PDF 47,241 KB, 119 pages)
4. Internal correspondence (PDF 166,355 KB, 67 pages)
5. Media correspondence (PDF 36,086 KB, 56 pages)
6. External correspondence (PDF 55,621 KB, 129 pages)
7. Company correspondence (PDF 178,224 KB, 210 pages)
8. MARC minutes (PDF 156,266 KB, 361 pages)

Submissions and advice, including Medsafe's response to the Health Select Committee following a petition requesting an inquiry into the numbers harmed by antiepileptic medicines during pregnancy can be accessed here: www.parliament.nz/en/pb/petitions/document/PET_78066/petition-of-denise-astill-inquiry-into-the-numbers-harmed